A Zava online doctor, or other healthcare professional, can then use the detailed analysis to decide how best to treat you.” Our app provides clear results and next steps with no confusing medical jargon. “Our aim is to make testing fast, accurate, and accessible for all. The test kit contains two tests and a free-to-download mobile application (available on iOS and Android), the TestCard solution is designed to be both affordable and accessible - to help reduce strain on the NHS and save time for both healthcare professionals and patients.ĭr Andrew Botham, co-founder & CSO at TestCard, said: “We are very excited to be launching a new partnership with Zava Online Doctor allowing alternative routes to important treatment for those that need it. The TestCard app provides clear answers as to whether a UTI has been detected and, where necessary, directs patients back to Zava for clinical advice and support. The Test and Treat service, in partnership with Zava, allows users to order a test from Zava’s Online Doctor with a consultation and a prescription delivered directly to patients’ homes.
Since 2011, Zava’s doctors have carried out almost 5 million consultations. Zava’s telemedicine platform provides access to consultations, testing and prescribed treatments from UK-based, GMC registered GPs. In addition, the company is looking to launch in the US in early 2023 and hence is currently working on obtaining FDA approval for its first product in the coming months.TestCard turns a smartphone camera into a clinical grade scanner, which along with its postcard test kit provides immediate results and a treatment referral where indicated. The app ensures safe and reliable Covid-19 antigen testing for patients, visitors and staff. The company also launched its integrated Covid-19 antigen testing solution, ClearScreen, into the NHS, in partnership with Guy’s and St Thomas’ Foundation Trust (GSTT), reducing admin time for hospital staff and improving traceability.
In Q1 2022, it launched in Rowlands and Lloyds Online Doctor. In 2021, TestCard secured extensive retail partnerships for its first product, a UTI test and treat service, with Superdrug Online Doctor, Weldricks, Chemist4U, Zava, Numark, Alphega and Amazon. The company’s key technology turns a typical smartphone into a clinical-grade scanner, allowing it to accurately read and interpret the results of rapid diagnostic medical tests, such as lateral flows and colorimetric dipsticks, making testing more accessible for consumers and transforming workflows in clinical settings. Led by CEO Chris Craig-Wood, TestCard has developed a healthcare technology platform that increases the accessibility and diagnostic capability of non-invasive testing. The company intends to use the funds to further commercialize its existing product suite whilst also launching new products such as diabetes, pregnancy, CKD and flu testing, and continue to invest in its technology underpinned by its IP portfolio. The latest round of fundraising was secured via corporate finance firm, West Hill Capital. TestCard, a UK-based MedTech company, raised USD10M in funding.
0 kommentar(er)
